Simi Valley, California, United States
I help diabetes-technology companies accelerate development and mitigate technology and programmatic risks. As a fractional executive and coach, I leverage years of experience spanning technology roles as an engineer, manager, director, VP, and CEO.
Advancing the state of the art in technologies to benefit people with diabetes
Advanced technology research
Led an extraordinary team of scientists, engineers, and technicians to develop the novel, FDA-cleared OS5000 (K162042) reagentless, critical care monitor for glucose. The OS7000 is CE Marked, providing continuous measurement of glucose, lactate and ScvO2 . Major innovations spanned mid-infrared, multivariate analyte measurement, sampling of blood automatically drawn from a central venous catheter, and an intuitive graphical user interface. The stellar team succeeded in bringing an unprecedented in vitro diagnostic device to connected critical care patients, earning a new FDA product code for a continuous glucose monitor. The company’s mission was impacted by the COVID-19 pandemic.
Medical device innovation development Technical due-diligence for venture-funded stories Innovation facilitation
Developed a novel insulin infusion pump system for people managing T1 diabetes. The architecture consisted of a durable component and a disposable drive assembly and a prefilled insulin cartridge.